Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2012
03/22/2012US20120070897 Method For Enucleating Nucleated Erythrocyte, And Enucleation Inducer
03/22/2012US20120070892 DNA Virus MicroRNA and Methods for Inhibiting Same
03/22/2012US20120070881 Bacillus licheniformis chromosome
03/22/2012US20120070875 Amino Acid Sequences which Enhance Peptide Conjugate Solubility
03/22/2012US20120070859 Bacterial cells, optimized nucleotide sequences and methods for improved expression of recombinant clostridium difficile toxin b
03/22/2012US20120070847 Method For Detecting And Purifying Pancreatic Beta Cells
03/22/2012US20120070827 Detection of fetal cells from maternal blood
03/22/2012US20120070826 Lafora's disease gene
03/22/2012US20120070561 Method for producing heat processed food
03/22/2012US20120070493 Targeted multi-epitope dosage forms for induction of an immune response to antigens
03/22/2012US20120070491 Casb7439 constructs
03/22/2012US20120070460 Dendritic cell modulatory molecule
03/22/2012US20120070457 Polypeptides from neisseria meningitidis
03/22/2012US20120070456 Polypeptide carrier protein
03/22/2012US20120070451 Methods and compositions for modulating cardiac contractility
03/22/2012US20120070443 Pde1 as a target therapeutic in heart disease
03/22/2012US20120070440 Therapeutic use of anti-cs1 antibodies
03/22/2012US20120070437 Method of identifying compounds that bind baff-r
03/22/2012US20120070435 Chimeric antigens for eliciting an immune response
03/22/2012US20120070434 Antibodies containing therapeutic tpo/epo mimetic peptides
03/22/2012US20120070430 Identification of tumor-associated markers for diagnosis and therapy
03/22/2012US20120070426 Peptide-based passive immunization therapy for the treatment of atherosclerosis
03/22/2012US20120070406 Therapeutic protein compositions having reduced immunogenicity and/or improved efficacy
03/22/2012US20120070375 Complex and contrast agent for photoimaging using the same
03/22/2012DE19735587B4 Peptid mit radioprotektiver Wirkung, dieses enthaltende kosmetische oder pharmazeutische Zusammensetzung, für dieses kodierende Nukleinsäure, Herstellungsverfahren für dieses Peptid und die Verwendung als radioprotektives Agens Peptide having radioprotective effect, cosmetic or pharmaceutical composition containing it, for this coding nucleic acid, production processes for this peptide and use as radioprotektives agent
03/22/2012CA2811538A1 Na+/mg2+ exchanger
03/22/2012CA2811493A1 Method for separating target molecules or particles from fibrinogen-containing samples including blood components
03/22/2012CA2811403A1 Bioproduction of aromatic chemicals from lignin-derived compounds
03/22/2012CA2811291A1 Treatment of chronic nephropathies using soluble complement receptor type i (scr1)
03/22/2012CA2811086A1 Step-derived peptide for brain injury treatment
03/22/2012CA2808675A1 Serpin-finger fusion polypeptide
03/22/2012CA2806322A1 Method for extracting undenatured type ii collagen having active epitope
03/21/2012EP2431480A2 Methods and compositions for increasing the stress resistance of cells and organisms
03/21/2012EP2431468A1 Interleukin-1 conjugates and uses thereof
03/21/2012EP2431460A2 Tsp-1, tsp-2, il-17br and hb-egf associated with stem cell activities and applications thereof
03/21/2012EP2431459A1 Components of cell culture media produced from plant cells
03/21/2012EP2431458A1 Components of cell culture media produced from plant cells
03/21/2012EP2431392A1 Antibodies against human IL-22 and uses therefor
03/21/2012EP2431390A1 Compositions and methods for modulating hemostasis
03/21/2012EP2431389A1 Compositions and methods for modulating hemostasis
03/21/2012EP2431388A1 Smoothened polypeptides and methods of use
03/21/2012EP2431387A1 A raft deficient yeast expression system for the production of recombinant membrane proteins
03/21/2012EP2431386A1 Na+/Mg2+ exchanger
03/21/2012EP2431385A2 Combination therapy with chlorotoxin
03/21/2012EP2431384A1 Method and device for extracting cedar pollen proteins
03/21/2012EP2431383A1 Polypeptides
03/21/2012EP2431382A1 Yersinia SPP, polypeptides and methods of use
03/21/2012EP2431381A2 Synthetic oligopeptides designed from mite cysteine proteases and methods for the production of igy polyclonal antibodies for the detection of intradomiciliary mites
03/21/2012EP2431055A1 Conjugates of membrane translocating agents and pharmaceutically active agents
03/21/2012EP2431054A2 Human tumor necrosis factor delta and epsilon
03/21/2012EP2431053A1 Novel glycosylated peptide target in neoplastic cells
03/21/2012EP2430923A1 Compositions and methods for liver growth and liver protection
03/21/2012EP2430453A1 Cmybp-c and mlc2 as diagnostic markers of cardiac injury
03/21/2012EP2430162A1 Dna sequences encoding caryophyllaceae and caryophyllaceae-like cyclopeptide precursors and methods of use
03/21/2012EP2430157A1 Antigen peptide and use thereof
03/21/2012EP2430156A1 Modified fluorescent proteins and methods for using same
03/21/2012EP2430044A1 Peptides increasing the secretion and/or expression of at least one gastrointestinal mucin and/or inducing an increase in the population of mucus cells or paneth cells
03/21/2012EP2430043A1 Nucleotide and amino acid sequences encoding an exported protein i derived from plasmodium vivax and uses thereof
03/21/2012EP2430042A1 Lipa and its variant useful for biofuel production
03/21/2012EP2430041A2 Cancer cell binding recombinant lectins with antitumor activity and method of preparation
03/21/2012EP2430040A1 Antigen purification process for pertactin antigen
03/21/2012EP2430038A2 Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory
03/21/2012EP2429567A1 Method of labelling interferons with peg
03/21/2012EP2429310A1 PRODUCTION OF CANOLA PROTEIN PRODUCT WITHOUT HEAT TREATMENT ("C200CaC")
03/21/2012EP2410058A9 Modification of flavonoid biosynthesis in plants with transparent testa 2
03/21/2012EP2320946B1 Allergoids derived from allergenes
03/21/2012EP2185588B9 Synthetic pulmonary surfactant peptides
03/21/2012EP2167531B1 Streptococcus pneumoniae pilus antigens
03/21/2012EP2162463B1 Vegf-d mutants and their use
03/21/2012EP2152732B1 A modified secretion system to increase expression of polypeptides in bacteria
03/21/2012EP2097110B1 Biological pacemakers including mutated hyperpolarization-activated cyclic nucleotide-gated (hcn) channels
03/21/2012EP2016102B1 Chimeric t cell receptors and related materials and methods of use
03/21/2012EP1966244B1 Anti-il-6 antibodies preventing the binding of il-6 complexed with il-6ralpha to gp130
03/21/2012EP1708755B1 Transglutaminase mediated conjugation of peptides
03/21/2012EP1668137B8 Enhancing accumulation of heterologous polypeptides in plant seeds through targeted suppression of endogenous storage proteins
03/21/2012EP1650302B1 Protein capable of deposition onto extracellular matrix
03/21/2012EP1532142B1 Polypeptide cleavage process
03/21/2012EP1515988B1 Dna sequence and recombinant production of the grass pollen allergen phl p4
03/21/2012EP1387854B1 Sfrp and peptide motifs that interact with sfrp and methods of their use
03/21/2012EP1320540B9 Peptidomimetic protease inhibitors
03/21/2012EP1088077B2 Newcastle disease virus infectious clones, vaccines and diagnostic assays
03/21/2012CN1946430B Therapeutic agent for treatment of cancer comprising human apolipoprotein (A) kringles LK68 or LK8 genes as effective ingredient, and method for treating cancer using the same
03/21/2012CN1934720B Semiconductor light-emitting device and illuminating device
03/21/2012CN1756843B Streptococcus pyogenes antigens
03/21/2012CN1554764B Recombinant mva virus, and the use thereof
03/21/2012CN1398964B Prepn of L-arginine
03/21/2012CN102388143A Axmi-150 delta-endotoxin gene and methods for its use
03/21/2012CN102388140A Aberrant mitochondrial DNA, associated fusion transcripts and translation products and hybridization probes therefor
03/21/2012CN102388094A Method for producing porous silk fibroin material
03/21/2012CN102388062A Trail variants for treating cancer
03/21/2012CN102388061A A method for binding a protein consisting of protein a or consisting of at least one domain of the a to e domains of the protein a to the substrate
03/21/2012CN102387813A Identification, optimization and use of cryptic hla-a24 epitopes for immunotherapy
03/21/2012CN102387794A Inhibition of biofilm organisms
03/21/2012CN102382853A Preparation method of vaccine mucosal immune adjuvant molecules
03/21/2012CN102382845A Method for producing porcine parvovirus antigen and its product
03/21/2012CN102382843A Sword-leaved cymbidium flowering integrator gene (CeFT gene) and application thereof
03/21/2012CN102382842A Analysis and utilization for gene function of PeCBL10 of populus euphratica olive
03/21/2012CN102382841A Analysis and utilization for gene function of PeNHX 1/3/6 of populus euphratica olive
03/21/2012CN102382840A Haliotis diversicolor calmodulin cDNA sequence
03/21/2012CN102382829A FBXL15 protein inhibitor and application thereof
1 ... 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 ... 2916